Subscribe to our press releases
ChromoGenics publishes the annual report 2017
ChromoGenics AB (publ) publishes the annual report 2017.
ChromoGenics annual report for 2017, in Swedish and translated into English, is now available on For investors in pdf-format. The annual report can also be ordered in print from the company and distributed via post to shareholders on demand.
The Annual General Meeting will take place Wednesday May 16, 2018 at 14.00 CET in Advokatfirman Lindahl’s offices on Vaksalagatan 10, Uppsala. Complete notifications and documents will be available at For investors and at the company at the time for the notice to AGM.
Thomas Almesjö, CEO
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on March 22, 2018, at 8:30 a.m. CET.
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.